1
by Gray, Casey, Ford, Caitlyn
Published 2018
CADTH
... of Bobath therapy for treatment of patients with neurological conditions as well as to summarize evidence...

2
Published 2014
Canadian Agency for Drugs and Technologies in Health
... to neurology, from musculo-skeletal imaging to cardiology. PET has been used with success for the evaluation...

3
by Gray, Casey, Ford, Caitlyn
Published 2018
CADTH
... of Bobath therapy for treatment of patients with neurological conditions as well as to summarize evidence...

6
by Khangura, Sara, Visintini, Sarah
Published 2018
CADTH
...Off-label Use of IVIG for non-neurological paraneoplastic disorders...

7
by Khangura, Sara, Visintini, Sarah
Published 2018
CADTH
...Off-label Use of IVIG for non-neurological paraneoplastic disorders...

8
Published 2019
Canadian Agency for Drugs and Technologies in Health

9
Published 2019
Canadian Agency for Drugs and Technologies in Health

10
Published 2020
Canadian Agency for Drugs and Technologies in Health
... that are relevant to the Canadian context on the neurological or cognitive development in children and adolescents...

11
Published 2020
Canadian Agency for Drugs and Technologies in Health
... severe drooling in patients three to 18 years of age with neurologic conditions (e.g., cerebral palsy [CP...

12
Published 2020
Canadian Agency for Drugs and Technologies in Health
... in patients three to 18 years of age with neurologic conditions associated with problem drooling...

13
Published 2020
Canadian Agency for Drugs and Technologies in Health
... to 18 years old with neurologic conditions associated with problem drooling (e.g., cerebral palsy...

14
Published 2014
Canadian Agency for Drugs and Technologies in Health
Subjects: ...Diagnostic Techniques, Neurological...

15
Published 2014
Canadian Agency for Drugs and Technologies in Health
Subjects: ...Diagnostic Techniques, Neurological...

16
by Ho, Chuong, Adcock, Lorna
Published 2018
CADTH
... of walking in patients with foot drop caused by various neurological conditions, but the effectiveness of FES...

17
by Ho, Chuong, Adcock, Lorna
Published 2018
CADTH
... of walking in patients with foot drop caused by various neurological conditions, but the effectiveness of FES...

18
Published 2013
Canadian Agency for Drugs and Technologies in Health
... hours of symptom onset, and it requires specific neurological expertise in order to guide the decision...

19
Published 2013
Canadian Agency for Drugs and Technologies in Health
... associated with 0.9% and 0.5% risk of transient and permanent neurologic deficits, respectively. Computed...

20
by Poitras, Veronica, Frey, Nina
Published 2017
Canadian Agency for Drugs and Technologies in Health
... hospital stay, who are undergoing surgery, or who have neurological deficits such as spinal cord injury...